Cargando…

What I have changed my mind about and why

This paper is based upon a panel discussion “What I Have Changed My Mind About and Why” held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting “Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.” The panel was chaired b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yehuda, Rachel, Spiegel, David, Southwick, Steven, Davis, Lori L., Neylan, Thomas C., Krystal, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106864/
https://www.ncbi.nlm.nih.gov/pubmed/27837585
http://dx.doi.org/10.3402/ejpt.v7.33768
_version_ 1782467136407470080
author Yehuda, Rachel
Spiegel, David
Southwick, Steven
Davis, Lori L.
Neylan, Thomas C.
Krystal, John H.
author_facet Yehuda, Rachel
Spiegel, David
Southwick, Steven
Davis, Lori L.
Neylan, Thomas C.
Krystal, John H.
author_sort Yehuda, Rachel
collection PubMed
description This paper is based upon a panel discussion “What I Have Changed My Mind About and Why” held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting “Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.” The panel was chaired by Professor Dr. Rachel Yehuda of the Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs, and included five clinician-scholars who exchanged thoughts about what they have changed their minds about over the years: Dr. David Spiegel, Dr. Steven Southwick, Dr. Lori Davis, Dr. Thomas Neylan, and Dr. John Krystal. This paper provides a summary of the salient points made by each expert and the questions and discussion that ensured. Major issues raised included the increasingly clear limitations to the fear-based model that has advanced the field. While treatments for PTSD have improved, there are some aspects of trauma exposure that cannot be entirely repaired. Research providing an evidence base to treatment has led to overly specific treatment guidelines that may obscure more general principles of effective treatment. Treatment might be viewed as a way to increase the plasticity of the brain in the context of processing social cues. A variety of novel and integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, enhancing well-being and resilience, and medications with novel mechanisms, such as ketamine. HIGHLIGHTS OF THE ARTICLE: The fear-based model has advanced the field but has clear limitations. There is a fundamental existential component to trauma that affects both patients and therapists. Integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, and enhancing well-being and resilience. Novel and promising therapies include medications like ketamine. It is important that we put new treatments to the test to prove that they work but not become overly specific in identifying treatment methods.
format Online
Article
Text
id pubmed-5106864
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-51068642016-11-18 What I have changed my mind about and why Yehuda, Rachel Spiegel, David Southwick, Steven Davis, Lori L. Neylan, Thomas C. Krystal, John H. Eur J Psychotraumatol Highlights from ISTSS 2015 This paper is based upon a panel discussion “What I Have Changed My Mind About and Why” held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting “Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.” The panel was chaired by Professor Dr. Rachel Yehuda of the Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs, and included five clinician-scholars who exchanged thoughts about what they have changed their minds about over the years: Dr. David Spiegel, Dr. Steven Southwick, Dr. Lori Davis, Dr. Thomas Neylan, and Dr. John Krystal. This paper provides a summary of the salient points made by each expert and the questions and discussion that ensured. Major issues raised included the increasingly clear limitations to the fear-based model that has advanced the field. While treatments for PTSD have improved, there are some aspects of trauma exposure that cannot be entirely repaired. Research providing an evidence base to treatment has led to overly specific treatment guidelines that may obscure more general principles of effective treatment. Treatment might be viewed as a way to increase the plasticity of the brain in the context of processing social cues. A variety of novel and integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, enhancing well-being and resilience, and medications with novel mechanisms, such as ketamine. HIGHLIGHTS OF THE ARTICLE: The fear-based model has advanced the field but has clear limitations. There is a fundamental existential component to trauma that affects both patients and therapists. Integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, and enhancing well-being and resilience. Novel and promising therapies include medications like ketamine. It is important that we put new treatments to the test to prove that they work but not become overly specific in identifying treatment methods. Co-Action Publishing 2016-11-08 /pmc/articles/PMC5106864/ /pubmed/27837585 http://dx.doi.org/10.3402/ejpt.v7.33768 Text en © 2016 Rachel Yehuda et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format, and to remix, transform, and build upon the material, for any purpose, even commercially, under the condition that appropriate credit is given, that a link to the license is provided, and that you indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
spellingShingle Highlights from ISTSS 2015
Yehuda, Rachel
Spiegel, David
Southwick, Steven
Davis, Lori L.
Neylan, Thomas C.
Krystal, John H.
What I have changed my mind about and why
title What I have changed my mind about and why
title_full What I have changed my mind about and why
title_fullStr What I have changed my mind about and why
title_full_unstemmed What I have changed my mind about and why
title_short What I have changed my mind about and why
title_sort what i have changed my mind about and why
topic Highlights from ISTSS 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106864/
https://www.ncbi.nlm.nih.gov/pubmed/27837585
http://dx.doi.org/10.3402/ejpt.v7.33768
work_keys_str_mv AT yehudarachel whatihavechangedmymindaboutandwhy
AT spiegeldavid whatihavechangedmymindaboutandwhy
AT southwicksteven whatihavechangedmymindaboutandwhy
AT davisloril whatihavechangedmymindaboutandwhy
AT neylanthomasc whatihavechangedmymindaboutandwhy
AT krystaljohnh whatihavechangedmymindaboutandwhy